Theranostic approaches in nuclear oncology: From bench to bed.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, n. 10, p. 612, doi. 10.1002/jlcr.3787
- By:
- Publication type:
- Article
Works in Journal of Labelled Compounds & Radiopharmaceuticals, 2019, Vol 62, Issue 10
Results: 7
1
2
Radiometals for imaging and theranostics, current production, and future perspectives.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, n. 10, p. 615, doi. 10.1002/jlcr.3770
- By:
- Publication type:
- Article
3
Design and development of the theranostic pair <sup>177</sup>Lu‐OPS201/<sup>68</sup>Ga‐OPS202 for targeting somatostatin receptor expressing tumors.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, n. 10, p. 635, doi. 10.1002/jlcr.3755
- By:
- Publication type:
- Article
4
Exendin‐4 analogs in insulinoma theranostics.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, n. 10, p. 656, doi. 10.1002/jlcr.3750
- By:
- Publication type:
- Article
5
Comparative evaluation of the new GRPR‐antagonist <sup>111</sup>In‐SB9 and <sup>111</sup>In‐AMBA in prostate cancer models: Implications of in vivo stability.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, n. 10, p. 646, doi. 10.1002/jlcr.3733
- By:
- Publication type:
- Article
6
Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examples.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, n. 10, p. 673, doi. 10.1002/jlcr.3712
- By:
- Publication type:
- Article
7
Issue Information.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, n. 10, p. 609, doi. 10.1002/jlcr.3661
- Publication type:
- Article